Filing Details

Accession Number:
0001127602-11-014646
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-03 15:23:38
Reporting Period:
2011-05-02
Filing Date:
2011-05-03
Accepted Time:
2011-05-03 15:23:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1016361 S Gavin Herbert 2525 Dupont Drive
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-05-02 5,000 $80.00 25,000 No 4 S Indirect By Successor Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Successor Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 400 Indirect By Spouse
Common Stock 14,400 Direct
Common Stock 166,560 Indirect By Family Trust
Common Stock 5,000 Indirect By Gavin S. Herbert Trust
Common Stock 3,400 Indirect By Spouse Living Trust
Footnotes
  1. The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2010, as co-trustee for the below described Successor Trust.
  2. Shares held by G. Herbert, Inc., which in turn is wholly owned by Gavin Herbert Successor Trust (GHST). The reporting person is co-trustee and has a pecuniary interest in GHST.
  3. Shares held by the Herbert Family Trust. Reporting person is trustee and beneficiary of this trust and has the power to revoke without another's consent.
  4. Shares held by Gavin S. Herbert Trust. The reporting person is beneficiary of this trust.
  5. Shares held by Ninetta Herbert Living Trust. The reporting person's spouse is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purposes.